Dermatology

Wide local excision and Mohs surgery are the leading treatments for melanoma patients with positive tumor margins, according to findings presented at the American Society for Dermatologic Surgery Annual Meeting.

Nutritional and microbial strategies are emerging as pivotal in treating skin conditions such as acne, alopecia, and atopic dermatitis.

Nearly half of patients with metastatic melanoma treated with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab have survived cancer-free, underscoring the impact of immunotherapy in advanced melanoma.

A major randomized clinical trial has demonstrated that home-based narrowband UV-B phototherapy is as effective as office-based treatment for patients with plaque or guttate psoriasis.

A clinical trial has shown that dupilumab, a monoclonal antibody targeting IL-4 and IL-13, may offer benefits to patients in managing bullous pemphigoid, a rare autoimmune blistering disease.

A strong link between childhood obesity and the development of immune-mediated skin diseases has been highlighted in new research.   

Approval has been granted by the FDA for lebrikizumab-lbkz in treating moderate to severe atopic dermatitis in patients aged 12 and older.

Gaps in dermatology education have been spotlighted in preclinical medical students.